- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 10.09M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 10.09M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 10.09M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $709K |
| Capex | Q1 2026 · Mar 31, 2025 | $552K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $608K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.56M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $49.76M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $53.23M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $82.86M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $84.19M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $13.85M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $15.96M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $18.69M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $20.95M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $79.25M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $83.02M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $101.31M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $104.95M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.21 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.35 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.35 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.77M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.89M |
| Net Income | Q1 2026 · Mar 31, 2026 | $2.08M |
| Net Income | Q1 2026 · Mar 31, 2025 | $3.57M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $2.31M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $4.05M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $13.09M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $14.07M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $10.01M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $9.26M |
| Revenue | Q1 2026 · Mar 31, 2026 | $23.09M |
| Revenue | Q1 2026 · Mar 31, 2025 | $23.33M |